iCellate has been voted an organizational member of NACG


NACG, the leading clinical precision medicine initiative in the Nordic Countries, aims to:

  • Facilitate the responsible sharing of genomic data, bioinformatics tools, sequencing methods and best practices for interpretation of genomic data.
  • Enhance quality of genomic data and processes, and explore methodologies to provide assurance.
  • Understand legal barriers to the implementation of personalised medicine and to engage with key stakeholders that influence these barriers
  • Develop demonstration projects that challenge perceived legal barriers that limit responsible and ethical sharing of genomic and health data.
  • Build bridges between research and clinical communities, technologies and practices to foster innovation